Expressed Protein Selenoester Ligation.
Expressed Protein Selenoesters
Peptides
Protein Modifications
Protein Semi-Synthesis
Proteins
Journal
Angewandte Chemie (Weinheim an der Bergstrasse, Germany)
ISSN: 0044-8249
Titre abrégé: Angew Chem Weinheim Bergstr Ger
Pays: Germany
ID NLM: 100955692
Informations de publication
Date de publication:
09 May 2022
09 May 2022
Historique:
received:
05
01
2022
medline:
9
5
2022
pubmed:
9
5
2022
entrez:
20
3
2024
Statut:
ppublish
Résumé
Herein, we describe the development and application of a novel expressed protein selenoester ligation (EPSL) methodology for the one-pot semi-synthesis of modified proteins. EPSL harnesses the rapid kinetics of ligation reactions between modified synthetic selenopeptides and protein aryl selenoesters (generated from expressed intein fusion precursors) followed by in situ chemoselective deselenization to afford target proteins at concentrations that preclude the use of traditional ligation methods. The utility of the EPSL technology is showcased through the efficient semi-synthesis of ubiquitinated polypeptides, lipidated analogues of the membrane-associated GTPase YPT6, and site-specifically phosphorylated variants of the oligomeric chaperone protein Hsp27 at high dilution. An expressed protein selenoester ligation (EPSL) methodology that enables the efficient semi‐synthesis of site‐specifically modified proteins at high dilution is described. EPSL involves the one‐pot conversion of protein acyl hydrazides (derived from recombinant intein fusion precursors) to protein aryl selenoesters, followed by ligation with synthetic modified selenopeptides and chemoselective deselenization.
Autres résumés
Type: Publisher
(ger)
An expressed protein selenoester ligation (EPSL) methodology that enables the efficient semi‐synthesis of site‐specifically modified proteins at high dilution is described. EPSL involves the one‐pot conversion of protein acyl hydrazides (derived from recombinant intein fusion precursors) to protein aryl selenoesters, followed by ligation with synthetic modified selenopeptides and chemoselective deselenization.
Identifiants
pubmed: 38505698
doi: 10.1002/ange.202200163
pii: ANGE202200163
pmc: PMC10947028
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e202200163Informations de copyright
© 2022 The Authors. Angewandte Chemie published by Wiley-VCH GmbH.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.